Bex Childress
Lawyers
Filters
TTX $300 million medium-term note offering
The investment-grade notes are due 2052
SiTime at-the-market offering
The stock offering is SEC-registered
AN2 Therapeutics $69 million IPO
The shares are listed on the Nasdaq Global Select Market
Credo Technology Group $200 million IPO
We advised Credo Technology on its IPO and Nasdaq listing